Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: Boyce Burge who wrote (70)	3/10/1998 12:01:00 AM
From: Richard Haugland	Read Replies (1) \| Respond to of 359

Yes, Roger Tsien is an impressive researcher with strong credentials so it does not surprise me that he impressed them even at Stanford. You are right that he is both a good organic chemist and a good physiologist/biologist but he also is strong at microscopy and computer programming. His brother Richard is on the Stanford faculty. Roger originally made a name for himself by developing indicators for intracellular ions (especially one called "fura-2"). It was following sales of these probes that my company (Molecular Probes) began to thrive. He has moved onto other areas of live cells probes, many of which can be used for high-throughput screening. Most likely most of this research cost does not appear directly on ABSC's balance sheet but is paid by the NIH and has, in general, been exclusively licensed to ABSC. Apparently his lab is also a recruiting center and Roger has had several good postdocs in the past. Incidentally, Tim Rink, the CEO of ABSC and Roger collaborated on much of the early work on cell indicators about 12-15 years ago.